Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease

Ann Hepatol. 2020 May-Jun;19(3):227-229. doi: 10.1016/j.aohep.2020.04.001.

Authors

Alejandro Valencia-Rodríguez¹, Alfonso Vera-Barajas¹, Norberto C Chávez-Tapia¹, Misael Uribe¹, Nahum Méndez-Sánchez²

Affiliations

¹ Liver Research Unit, Medica Sur Clinical Foundation, Mexico City, Mexico.
² Liver Research Unit, Medica Sur Clinical Foundation, Mexico City, Mexico; Faculty of Medicine. National Autonomous University of Mexico, Mexico City, Mexico. Electronic address: nmendez@medicasur.org.mx.

PMID: 32359519
DOI: 10.1016/j.aohep.2020.04.001

No abstract available

Publication types

Letter
Comment

MeSH terms

Consensus
Humans
Non-alcoholic Fatty Liver Disease*